These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 8014881)
1. Characterization of rat pulmonary vascular aminopeptidase P in vivo: role in the inactivation of bradykinin. Ryan JW; Berryer P; Chung AY; Sheffy DH J Pharmacol Exp Ther; 1994 Jun; 269(3):941-7. PubMed ID: 8014881 [TBL] [Abstract][Full Text] [Related]
2. Species variation in pulmonary endothelial aminopeptidase P activity. Chen X; Orfanos SE; Ryan JW; Chung AY; Hess DC; Catravas JD J Pharmacol Exp Ther; 1991 Dec; 259(3):1301-7. PubMed ID: 1762077 [TBL] [Abstract][Full Text] [Related]
3. Hypotensive effects of hemopressin and bradykinin in rabbits, rats and mice. A comparative study. Blais PA; Côté J; Morin J; Larouche A; Gendron G; Fortier A; Regoli D; Neugebauer W; Gobeil F Peptides; 2005 Aug; 26(8):1317-22. PubMed ID: 16042973 [TBL] [Abstract][Full Text] [Related]
4. Effect of a new aminopeptidase P inhibitor, apstatin, on bradykinin degradation in the rat lung. Prechel MM; Orawski AT; Maggiora LL; Simmons WH J Pharmacol Exp Ther; 1995 Dec; 275(3):1136-42. PubMed ID: 8531074 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of both aminopeptidase P and angiotensin-converting enzyme prevents bradykinin degradation in the rat coronary circulation. Erşahin C; Simmons WH J Cardiovasc Pharmacol; 1997 Jul; 30(1):96-101. PubMed ID: 9268227 [TBL] [Abstract][Full Text] [Related]
6. Kinin metabolism in the perfused ventilated rat lung. I: Bradykinin metabolism in a system modeling the normal, uninjured lung. Baker CR; Little AD; Little GH; Canizaro PC; Behal FJ Circ Shock; 1991 Jan; 33(1):37-47. PubMed ID: 2009602 [TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo characterization of bradykinin B2 receptors in the rabbit and the guinea pig. Gobeil F; Filteau C; Pheng LH; Jukic D; Nguyen-Le XK; Regoli D Can J Physiol Pharmacol; 1996 Feb; 74(2):137-44. PubMed ID: 8723025 [TBL] [Abstract][Full Text] [Related]
8. Depressor action of bradykinin agonists relative to metabolism by angiotensin-converting enzyme, carboxypeptidase N, and aminopeptidase P. Ahmad S; Ward PE Proc Soc Exp Biol Med; 1992 May; 200(1):115-21. PubMed ID: 1315058 [TBL] [Abstract][Full Text] [Related]
9. Metabolism of bradykinin agonists and antagonists by plasma aminopeptidase P. Ward PE; Chow A; Drapeau G Biochem Pharmacol; 1991 Jul; 42(4):721-7. PubMed ID: 1651078 [TBL] [Abstract][Full Text] [Related]
10. Development and in vivo evaluation of metabolically resistant antagonists of B1 receptors for kinins. Drapeau G; Audet R; Levesque L; Godin D; Marceau F J Pharmacol Exp Ther; 1993 Jul; 266(1):192-9. PubMed ID: 8392550 [TBL] [Abstract][Full Text] [Related]
11. Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats. Campbell DJ; Anastasopoulos F; Duncan AM; James GM; Kladis A; Briscoe TA J Pharmacol Exp Ther; 1998 Nov; 287(2):567-77. PubMed ID: 9808682 [TBL] [Abstract][Full Text] [Related]
12. Estimation of rate constants for reactions of pulmonary microvascular angiotensin converting enzyme with an inhibitor and a substrate in vivo. Ryan JW; Valido FA; Sequeira MJ; Chung AY; Berryer P; Chen XL; Catravas JD J Pharmacol Exp Ther; 1994 Jul; 270(1):260-8. PubMed ID: 8035324 [TBL] [Abstract][Full Text] [Related]
13. Effect of a fibrin-derived vasoactive peptide on pulmonary angiotensin converting enzyme activity and on pressure responses to bradykinin. Moalli R; Saldeen K; Saldeen T J Pharmacol Exp Ther; 1987 Dec; 243(3):897-900. PubMed ID: 3694536 [TBL] [Abstract][Full Text] [Related]
14. Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors. Georgiadis D; Beau F; Czarny B; Cotton J; Yiotakis A; Dive V Circ Res; 2003 Jul; 93(2):148-54. PubMed ID: 12805239 [TBL] [Abstract][Full Text] [Related]
15. Do the cardiovascular effects of angiotensin-converting enzyme (ACE) I involve ACE-independent mechanisms? new insights from proline-rich peptides of Bothrops jararaca. Ianzer D; Santos RA; Etelvino GM; Xavier CH; de Almeida Santos J; Mendes EP; Machado LT; Prezoto BC; Dive V; de Camargo AC J Pharmacol Exp Ther; 2007 Aug; 322(2):795-805. PubMed ID: 17475904 [TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme, bradykinin, and angiotensin II receptor binding in rat skin, tendon, and heart valves: an in vitro, quantitative autoradiographic study. Sun Y; Diaz-Arias AA; Weber KT J Lab Clin Med; 1994 Mar; 123(3):372-7. PubMed ID: 8133148 [TBL] [Abstract][Full Text] [Related]
17. Bradykinin in ischemia-reperfusion injury of the rat lung. Nowak K; Weih S; Post S; Gebhard MM; Hohenberger P J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):513-22. PubMed ID: 18204165 [TBL] [Abstract][Full Text] [Related]
18. Degradation of bradykinin, a cardioprotective substance, during a single passage through isolated rat-heart. Ahmad M; Zeitlin IJ; Parratt JR; Pitt AR Arch Pharm Res; 2006 Mar; 29(3):241-8. PubMed ID: 16596998 [TBL] [Abstract][Full Text] [Related]
19. Assay of pulmonary microvascular endothelial angiotensin-converting enzyme in vivo: comparison of three probes. Orfanos SE; Chen XL; Ryan JW; Chung AY; Burch SE; Catravas JD Toxicol Appl Pharmacol; 1994 Jan; 124(1):99-111. PubMed ID: 8291066 [TBL] [Abstract][Full Text] [Related]
20. Fate of bradykinin on the rat liver when administered by the venous or arterial route. Gioli-Pereira L; Nascimento EA; Santos EL; Bracht A; Juliano MA; Pesquero JB; Borges DR; Kouyoumdjian M J Gastroenterol Hepatol; 2005 Mar; 20(3):463-73. PubMed ID: 15740493 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]